Generation of vascular chimerism within donor organs.
Animals
Chimerism
Endothelial Cells
/ cytology
Female
Hindlimb
/ blood supply
Organ Culture Techniques
Rats
Rats, Sprague-Dawley
Regenerative Medicine
/ methods
Swine
Tissue Engineering
/ methods
Tissue Scaffolds
Tissue and Organ Harvesting
Transplantation Chimera
/ anatomy & histology
Transplantation, Heterologous
/ methods
Viscera
/ blood supply
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
28 06 2021
28 06 2021
Historique:
received:
26
01
2021
accepted:
16
06
2021
entrez:
29
6
2021
pubmed:
30
6
2021
medline:
9
11
2021
Statut:
epublish
Résumé
Whole organ perfusion decellularization has been proposed as a promising method to generate non-immunogenic organs from allogeneic and xenogeneic donors. However, the ability to recellularize organ scaffolds with multiple patient-specific cells in a spatially controlled manner remains challenging. Here, we propose that replacing donor endothelial cells alone, while keeping the rest of the organ viable and functional, is more technically feasible, and may offer a significant shortcut in the efforts to engineer transplantable organs. Vascular decellularization was achieved ex vivo, under controlled machine perfusion conditions, in various rat and porcine organs, including the kidneys, liver, lungs, heart, aorta, hind limbs, and pancreas. In addition, vascular decellularization of selected organs was performed in situ, within the donor body, achieving better control over the perfusion process. Human placenta-derived endothelial progenitor cells (EPCs) were used as immunologically-acceptable human cells to repopulate the luminal surface of de-endothelialized aorta (in vitro), kidneys, lungs and hind limbs (ex vivo). This study provides evidence that artificially generating vascular chimerism is feasible and could potentially pave the way for crossing the immunological barrier to xenotransplantation, as well as reducing the immunological burden of allogeneic grafts.
Identifiants
pubmed: 34183759
doi: 10.1038/s41598-021-92823-7
pii: 10.1038/s41598-021-92823-7
pmc: PMC8238957
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
13437Références
Am J Transplant. 2020 Jan;20 Suppl s1:20-130
pubmed: 31898417
Sci Rep. 2018 Mar 22;8(1):5014
pubmed: 29568084
Stem Cells Transl Med. 2016 Apr;5(4):530-8
pubmed: 26956207
Xenotransplantation. 2007 Nov;14(6):591-602
pubmed: 17991147
Nat Biomed Eng. 2021 Feb;5(2):134-143
pubmed: 32958897
J Clin Invest. 2018 Jan 2;128(1):219-232
pubmed: 29202467
Am J Transplant. 2019 May;19(5):1328-1343
pubmed: 30506641
Am J Transplant. 2015 Jul;15(7):1748-54
pubmed: 25807965
Nat Commun. 2017 Aug 4;8(1):191
pubmed: 28775323
Biomaterials. 2015 Feb;40:72-9
pubmed: 25433603
Acta Biomater. 2017 Mar 1;50:207-219
pubmed: 27993639
Liver Transpl. 2001 Oct;7(10):918-20
pubmed: 11679993
Artif Organs. 2020 Oct;44(10):1073-1080
pubmed: 32299137
Tissue Eng Part B Rev. 2018 Feb;24(1):1-24
pubmed: 28548628
Science. 2010 Jul 30;329(5991):538-41
pubmed: 20576850
J Clin Invest. 2001 Jun;107(11):1411-22
pubmed: 11390423
Sci Rep. 2017 Aug 16;7(1):8447
pubmed: 28814761
Vet Immunol Immunopathol. 1994 Oct;43(1-3):185-91
pubmed: 7856051
J Tissue Eng Regen Med. 2018 Mar;12(3):e1704-e1715
pubmed: 29084373
Nat Protoc. 2010 Apr;5(4):628-35
pubmed: 20224563
Nat Biotechnol. 2015 Oct;33(10):1097-102
pubmed: 26368048
Transpl Int. 2019 Jun;32(6):571-585
pubmed: 31099920
Nat Biotechnol. 2020 Mar;38(3):297-302
pubmed: 32094659
Immunity. 2001 Apr;14(4):437-46
pubmed: 11336689
Front Immunol. 2020 Feb 19;11:265
pubmed: 32140158
Xenotransplantation. 2019 Jul;26(4):e12516
pubmed: 30989742
J Immunol. 2015 Feb 15;194(4):1534-44
pubmed: 25560409
Nat Biomed Eng. 2020 Apr;4(4):437-445
pubmed: 31611679
Nat Med. 2003 Jan;9(1):53-60
pubmed: 12496960
Am J Transplant. 2020 Jan;20 Suppl s1:427-508
pubmed: 31898416
Stem Cell Reports. 2020 Apr 14;14(4):538-540
pubmed: 32294412
J Transplant. 2011;2011:501749
pubmed: 21234246
Acta Biomater. 2018 Sep 15;78:151-164
pubmed: 30071351
Sci Transl Med. 2019 Mar 27;11(485):
pubmed: 30918113
Science. 2003 Jan 17;299(5605):411-4
pubmed: 12493821
Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11450-5
pubmed: 16055556
Nat Rev Nephrol. 2019 Feb;15(2):87-108
pubmed: 30607032
Transplantation. 2010 Dec 27;90(12):1294-8
pubmed: 21076377
Hum Gene Ther. 2019 Apr;30(4):485-496
pubmed: 30261752
Annu Rev Biomed Eng. 2011 Aug 15;13:27-53
pubmed: 21417722
Lancet. 2001 Mar 24;357(9260):932-3
pubmed: 11289353
Proc Natl Acad Sci U S A. 2009 May 26;106(21):8659-64
pubmed: 19433788
Liver Transpl. 2003 Jun;9(6):552-6
pubmed: 12783394
NPJ Regen Med. 2019 Dec 2;4:22
pubmed: 31815001
Transplantation. 2008 Nov 27;86(10):1340-8
pubmed: 19034000
Ann Surg. 2018 Mar;267(3):590-598
pubmed: 28085694
Lab Invest. 2000 Jun;80(6):815-30
pubmed: 10879733
N Engl J Med. 2002 Jan 3;346(1):5-15
pubmed: 11777997
Transplantation. 2006 Jul 15;82(1 Suppl):S25-9
pubmed: 16829790
Int J Cancer. 2013 Sep 15;133(6):1334-44
pubmed: 23463345
Sci Rep. 2016 Jun 29;6:29081
pubmed: 27353424
Tissue Eng Part C Methods. 2016 May;22(5):439-50
pubmed: 26935764
Sci Rep. 2019 May 29;9(1):8001
pubmed: 31142801
Stem Cells Transl Med. 2016 Mar;5(3):291-300
pubmed: 26819255
Br J Clin Pharmacol. 2009 Oct;68(4):484-92
pubmed: 19843051
Sci Immunol. 2019 Jan 11;4(31):
pubmed: 30635356
Transpl Immunol. 2006 Jan;15(3):211-5
pubmed: 16431288
Nat Biotechnol. 2017 Jun 7;35(6):530-542
pubmed: 28591112
Xenotransplantation. 2016 Mar;23(2):83-105
pubmed: 26813438
Lancet. 2001 Jan 6;357(9249):33-7
pubmed: 11197359